Our collaboration with people affected by rare diseases makes bold science possible.
A nimble and unique organization, Enzyvant has a full range of capabilities spanning non-clinical and clinical development and commercialization and is developing in-house manufacturing.
We prioritize collaborative connections with patients, caregivers, academia, industry, associations, advocacy and the government to accelerate transformative medicines that are urgently needed.
We are purpose-driven and we do not give up, choosing the biggest challenges impacting the rare disease community today. We adapt. We follow through and we succeed. Because in rare diseases, the communities are small and the human need is immense.